COVID-19
5,271
157
289
2,819
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
611 trials with published results (12%)
Research Maturity
2819 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.6%
402 terminated out of 5271 trials
87.5%
+1.0% vs benchmark
13%
665 trials in Phase 3/4
22%
611 of 2819 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2819 completed trials
Clinical Trials (5271)
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
COVID-19 Experiences in the SELF Cohort
Arginine Replacement Therapy in COVID-19
Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults
C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome
A Longitudinal Study of COVID-19 Sequelae and Immunity
A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
The Nanowear Wearable Covid-19 Observational and Analysis Trend
Noseguard for Prevention of Respiratory Infections in Real-World Use
The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Respiratory Virus Sampling and Repository
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl